Stryker Corp (SYK)

Medtronic grew revenue by 14% in the first quarter of its fiscal 2027.

What happened? Shares of medical technology company Stryker (NYSE:SYK) fell 4.2% in the morning session after the company reported third-quarter results mark...

Medical technology company Stryker (NYSE:SYK) fell short of the market’s revenue expectations in Q3 2026, but sales rose 7.6% year on year to $6.52 billion. ...

Hip and knee procedures slow as patient affordability pressures weigh on results.

Stryker (NYSE:SYK) reported third-quarter organic sales growth of 7.7% and adjusted earnings per share of $3.52, while lowering its full-year outlook to reflect a slowdown in hip and knee procedures, lingering peripheral vascular supply constraints and execution risks tied to capital equipment sales

Medical technology company Stryker (NYSE:SYK) missed Wall Street’s revenue expectations in Q3 2026, but revenue rose 7.6% year on year to $6.52 billion. Its ...

Medical technology company Stryker (NYSE:SYK) will be reporting earnings this Thursday afternoon. Here’s what investors should know. Stryker met analysts’ re...

Two industry leaders offer different paths to long-term wealth.

Every Rule Breaker investor eventually has to ask whether great leadership can outlive the people who built a company.

Over the past six months, Stryker’s shares (currently trading at $277.82) have posted a disappointing 20% loss, well below the S&P 500’s 12.8% gain. This may...

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...

Analysts think this beaten-down healthcare stock will rebound.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...